ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Wize Pharma Announces Positive Results for Dry Eye Syndrome in Sjögren's Syndrome
November 25, 2020Wize Pharma reported topline results from its Phase IV clinical trial of its in-license eye drop formula, LO2A, for the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren's syndrome. -
Wize Pharma Completes Phase IV Study of LO2A for Dry Eye Syndrome with Sjögren's Syndrome
May 12, 2020Wize Pharma has completed treating patients in its Phase IV clinical trial of its prescription eye drop formula, LO2A, for the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren's syndrome. -
Wize Pharma raises $1.14 Million
March 05, 2018A portion of the proceeds will be used for clinical studies that are evaluating the efficacy of LO2A in the treatment of dry eye syndrome
Pharma Sources Insight January 2025
